20
Participants
Start Date
August 31, 2014
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2023
TGI SVF material via intramuscular injection
Each SVF-treated subject will receive up to 30 cc of the TGI SVF material via intramuscular injection (injections at multiple locations on the lower leg - up to 20 total injections) through a 23 gauge needle over a 2- to 4- minute period.
Indiana University Hospital, Indianapolis
Lead Sponsor
U.S. Army Medical Research and Development Command
FED
Tissue Genesis
INDUSTRY